Azenta (AZTA) Stock Price, News & Analysis

Company Overview

Azenta, Inc. provides products and services for life sciences research and the management of biological samples. Its offerings include automated sample storage systems, laboratory automation equipment, consumables, and software used to track and manage samples.

The company also provides genomic services through GENEWIZ, including sequencing and other genetic analysis services for researchers and organizations in the life sciences and pharmaceutical industries.

Azenta was formed in 2021 when Brooks Automation separated its life sciences business and adopted the Azenta name. The company serves customers in multiple regions, including North America, Europe, and Asia.

Key Stats

• Today's Range: $43.15 to $44.57
• 50-Day Range: $30.15 to $48.90
• 52-Week Range: $15.93 to $50.06
• Volume: 125,897 shs
• Average Volume: 942,154 shs
• Market Capitalization: $1.91 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $47.60
• Consensus Rating: Hold

Azenta Stock Analysis - MarketRank™

Azenta scored higher than 25% of companies evaluated by MarketBeat, and ranked 801st out of 892 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.6 / 5
• Analyst Rating: Hold

Consensus Rating

Azenta has received a consensus rating of Hold. The company's average rating score is 2.43, and is based on no strong buy ratings, 4 buy ratings, 2 hold ratings, and 1 sell rating.

Upside/Downside

The consensus price target for Azenta is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

Azenta has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Azenta is -12.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Azenta is -12.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Azenta has a P/B Ratio of 1.36. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

13.85% of the float of Azenta has been sold short.

Short Interest Ratio / Days to Cover

Azenta has a short interest ratio ("days to cover") of 6.2.

Change versus previous month

Short interest in Azenta has recently increased by 0.79%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Azenta does not currently pay a dividend.

Dividend Growth

Azenta does not have a long track record of dividend growth.

News and Social Media

• Score: 2.8 / 5
• News Sentiment: 0.49

News Sentiment

Azenta has a news sentiment score of 0.49. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 37 news articles for Azenta this week, compared to 4 articles on an average week.

Search Interest

4 people have searched for AZTA on MarketBeat in the last 30 days.

Company Ownership

• Score: 1.1 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Azenta insiders have not sold or bought any company stock.

Percentage Held by Insiders

10.90% of the stock of Azenta is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

99.08% of the stock of Azenta is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 11/10/2026
• Today: 11/13/2026
• Fiscal Year End: 9/30/2027

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Life Sciences Tools & Services
• Sub-Industry: Life Sciences Tools & Services
• Current Symbol: NASDAQ:AZTA
• CIK: 933974
• Web: www.azenta.com
• Phone: (978) 262-2400
• Fax: 978-262-2500
• Employees: 3,000
• Year Founded: 1978

Price Target and Rating

• Average Price Target for Azenta: $47.60
• High Price Target: $57.00
• Low Price Target: $39.00
• Potential Upside/Downside: +9.3%
• Consensus Rating: Hold
• Rating Score (0-4): 2.43
• Research Coverage: 7 Analysts

Profitability

• EPS (Trailing Twelve Months): ($3.62)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$55.76 million
• Net Margins: -26.86%
• Pretax Margin: -24.29%
• Return on Equity: 1.41%
• Return on Assets: 1.15%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.68
• Quick Ratio: 2.21

Sales & Book Value

• Annual Sales: $621.70 million
• Price / Sales: 3.07
• Cash Flow: $4.59 per share
• Price / Cash Flow: 9.48
• Book Value: $31.89 per share
• Price / Book: 1.37

Miscellaneous

• Outstanding Shares: 43,810,000
• Free Float: 39,033,000
• Market Cap: $1.91 billion
• Optionable: Optionable
• Beta: 1.47